SISTER study: peer support may boost cancer treatment completion
NCT ID NCT04930159
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether group or one-on-one peer support helps Black patients with endometrial cancer complete their treatment and feel less isolated. About 252 participants will be randomly assigned to group support, one-on-one peer calls, or usual care. The main goal is to see if social support improves how much of the planned treatment they actually receive.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
social support (group or one-on-one peer support)
What this could lead to
If it works, this could show that structured social support helps Black patients complete their cancer treatment and feel less isolated.
What could go wrong
This is a relatively small, early-stage behavioral study. The support may not significantly improve treatment completion or social isolation, and results may not apply to other groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98105, United States
-
Johns Hopkins University
Baltimore, Maryland, 21218, United States
-
Louisiana State University - New Orleans
New Orleans, Louisiana, 70112, United States
-
MedStar Health Research Institute
Columbia, Maryland, 21044, United States
-
The University of Chicago
Chicago, Illinois, 60637, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Alabama
Birmingham, Alabama, 35294, United States
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
-
Weill Cornell Medicine
New York, New York, 10021, United States